|
|
Article: Presentations on the Mechanism of Action of VEGFb, the World's Only "Angiogenesis Modulator," Support VEGFb's Role as an Epical Treatment for Solid Cancers, Macular Degeneration, and Other Diseases.
- Article from:
- Angiogenesis Weekly
- Article date:
- September 19, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Increasingly, VEGFb is becoming recognized as a drug that will begin a new era in cancer treatment, due to its revolutionary mechanism of action. VEGFb is the world's only "angiogenesis modulator;" a drug that regresses pathological blood vessels (such as those in solid tumors, wet macular degeneration, and other disorders), promotes the formation of normal blood vessels, while also acting as an essential survival factor for endothelial cells, neurons, and other cells and tissues (see also PhiloGene, Inc.).
The European Congress on Microcirculation, held in Budapest, Hungary, featured a symposium focused on VEGFb on Aug 26(th) 2OO8. The results presented at this ...